Dali Pharmaceutical Co (SHSE:603963) Growth Rank : 1 (As of May. 27, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Dali Pharmaceutical Co Growth Rank?

Dali Pharmaceutical Co has the Growth Rank of 1.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Competitive Comparison of Dali Pharmaceutical Co's Growth Rank

For the Drug Manufacturers - Specialty & Generic subindustry, Dali Pharmaceutical Co's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dali Pharmaceutical Co's Growth Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dali Pharmaceutical Co's Growth Rank distribution charts can be found below:

* The bar in red indicates where Dali Pharmaceutical Co's Growth Rank falls into.

Dali Pharmaceutical Co Growth Rank Related Terms

Thank you for viewing the detailed overview of Dali Pharmaceutical Co's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Dali Pharmaceutical Co (SHSE:603963) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dali Pharmaceutical Co Ltd (SHSE:603963) » Definitions » Growth Rank

Traded in Other Exchanges

N/A

Address

No. 118, Huancheng West Road, Yunnan Province, Xiaguan Town, Dali, CHN, 671000

Website

http://www.daliyaoye.cn

Dali Pharmaceutical Co Ltd operates in the pharmaceutical manufacturing industry. It is engaged in the research and development and production of Chinese and Western medicine injection products. The company's main products are Zhongjing Brand Xingnaojing Injection, Shenmai Injection, Astragalus Injection, Brighten A Injection and Cell Diphosphocholine injection.

Executives

Wu Pei Rong	senior management
Yang Jun Xiang	Directors, senior managers
Yang Jun Wei	Director

Dali Pharmaceutical Co (SHSE:603963) Headlines

No Headlines